S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Global Biopharmaceutical Company UCB Expands Real Estate Services Relationship With JLL|
|Immunomedics Announces Six Presentations on Epratuzumab in Lupus at Leading Rheumatology Meeting|
|Dermira and UCB Announce Start of Phase 3 Program for CIMZIA(R) (certolizumab pegol) in Psoriasis|
|Immunomedics Announces Presentations at the 2014 European Association of Nuclear Medicine Congress|
|Immunomedics Announces European Orphan Drug Designation for Isactuzumab Govitecan for Pancreatic Cancer Treatment|
|Immunomedics to Present Updated Clinical Results With Solid-Tumor Antibody-Drug Conjugates at Upcoming Conferences|
|Immunomedics Announces Conference Call and Webcast for First Quarter Fiscal 2015 Financial Results|
|Immunomedics Announces First Quarter Fiscal 2015 Results and Clinical Program Developments|
|Immunomedics Provides Update on Phase 2 Study of Isactuzumab Govitecan in Patients With Diverse Metastatic Solid Cancers|
|Immunomedics Receives Third Edison Patent Award From Research & Development Council of New Jersey|
Click above to view more mutual fund data and stats for ucb - UCB SA.